45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
58,111
Insurances with rates
27
CPT / HCPCS codes
72
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 1980006 | Elevidys 1.33e13 VG/mL Inj (14.5-15.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980007 | Elevidys 1.33e13 VG/mL Inj (15.5-16.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980008 | Elevidys 1.33e13 VG/mL Inj (19.5-20.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980011 | Elevidys 1.33e13 VG/mL Inj (34.5-35.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980012 | Elevidys 1.33e13 VG/mL Inj (43.5-44.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980013 | Elevidys 1.33e13 VG/mL Inj (60.5-61.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980015 | Elevidys 1.33e13 VG/mL Inj (36.5-37.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980016 | Elevidys 1.33e13 VG/mL Inj (69.5kg-above) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980017 | Elevidys 1.33e13 VG/mL Inj (47.5-48.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980018 | Elevidys 1.33e13 VG/mL Inj (26.5-27.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980019 | Elevidys 1.33e13 VG/mL Inj (52.5–53.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980020 | Elevidys 1.33e13 VG/mL Inj (63.5-64.4kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980021 | Elevidys 1.33e13 VG/mL Inj (61.5-62.4 kg) | $9,600,000 | $8,640,000 | — | — | 2 |
| 1980001 | Zolgensma 2e13 VG/mL Inj (3.1-3.5kg) | $6,966,133 | $6,269,519 | — | — | 1 |
| 1980002 | Zolgensma 2e13 VG/mL Inj (3.6-4.0kg) | $6,966,133 | $6,269,519 | — | — | 1 |
| 1980003 | Zolgensma 2e13 VG/mL Inj (4.6-5.0kg) | $6,966,133 | $6,269,519 | — | — | 1 |
| 1980004 | Zolgensma 2e13 VG/mL Inj (6.6-7.0kg) | $6,966,133 | $6,269,519 | — | — | 1 |
| 1980014 | Zolgensma 2e13 VG/mL Inj (8.6-9.0kg) | $6,966,133 | $6,269,519 | — | — | 1 |
| 1980009 | tisagenlecleucel (ALL) Soln | $1,780,600 | $1,602,540 | — | — | 9 |
| 1980009 | tisagenlecleucel (ALL) Soln | $1,780,600 | $1,602,540 | — | — | 12 |
| 1980010 | tisagenlecleucel (DLBCL/FL) Soln | $1,466,781 | $1,320,103 | — | — | 9 |
| 1980010 | tisagenlecleucel (DLBCL/FL) Soln | $1,466,781 | $1,320,103 | — | — | 12 |
| 3925176 | nusinersen 12 mg/5 mL Inj | $592,007 | $532,806 | — | — | 7 |
| 3925176 | nusinersen 12 mg/5 mL Inj | $592,007 | $532,806 | — | — | 12 |
| 5060001 | KIDNEY ACQUI-LVNG DNR-SNG | $471,423 | $424,281 | — | — | 7 |
| 15065851 | SET UNIV FRAG ELBOW IMPL | $214,678 | $193,210 | — | — | 7 |
| 15065851 | SET UNIV FRAG ELBOW IMPL | $214,678 | $193,210 | — | — | 11 |
| 5060002 | KIDNEY ACQUI-CDVR DNR-LNT | $177,000 | $159,300 | — | — | 7 |
| 3925055 | glucarpidase 1000 units/mL Vial | $168,654 | $151,788 | — | — | 7 |
| 3925055 | glucarpidase 1000 units/mL Vial | $168,654 | $151,788 | — | — | 12 |
| 1980024 | emapalumab 100 mg/20 mL Vial | $144,774 | $130,297 | — | — | 7 |
| 1980024 | emapalumab 100 mg/20 mL Vial | $144,774 | $130,297 | — | — | 12 |
| 3925337 | cerliponase alfa 150 mg/5 mL Inj | $121,366 | $109,230 | — | — | 7 |
| 3925337 | cerliponase alfa 150 mg/5 mL Inj | $121,366 | $109,230 | — | — | 12 |
| 15064956 | GEN VNS DUO MODEL 1000D | $120,369 | $108,332 | — | — | 7 |
| 15064956 | GEN VNS DUO MODEL 1000D | $120,369 | $108,332 | — | — | 11 |
| 15026926 | COCHLR SYNCHRNY2 FLX28 | $113,775 | $102,398 | — | — | 7 |
| 15026926 | COCHLR SYNCHRNY2 FLX28 | $113,775 | $102,398 | — | — | 11 |
| 15030023 | IMP COCHLR SYNCHRNY 2PIN | $113,775 | $102,398 | — | — | 7 |
| 15030023 | IMP COCHLR SYNCHRNY 2PIN | $113,775 | $102,398 | — | — | 11 |
| 15030500 | IMP COCHLR SYNCHR | $113,775 | $102,398 | — | — | 7 |
| 15030500 | IMP COCHLR SYNCHR | $113,775 | $102,398 | — | — | 11 |
| 15069892 | COCHLEAR SYNCH 2 FLEX 28 | $113,775 | $102,398 | — | — | 7 |
| 15069892 | COCHLEAR SYNCH 2 FLEX 28 | $113,775 | $102,398 | — | — | 11 |
| 3925608 | calaspargase pegol-mknl 5 mL Vial | $113,326 | $101,993 | — | — | 7 |
| 3925608 | calaspargase pegol-mknl 5 mL Vial | $113,326 | $101,993 | — | — | 12 |
| 15023076 | GENERATOR ASPIRE MODEL 16 | $106,989 | $96,290 | — | — | 7 |
| 15023076 | GENERATOR ASPIRE MODEL 16 | $106,989 | $96,290 | — | — | 11 |
| 15023262 | IMPLT COCHLR SYNCHRNY PI8 | $105,000 | $94,500 | — | — | 7 |
| 15023262 | IMPLT COCHLR SYNCHRNY PI8 | $105,000 | $94,500 | — | — | 11 |
Showing top 50 of 58,111 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.